The COVID-19 pandemic continues to pose significant challenges to global public health, necessitating the development of effective vaccination strategies to mitigate disease transmission. In Thailand, the COVID-19 epidemic has undergone multiple waves, prompting the implementation of various control measures, including vaccination campaigns. Understanding the dynamics of disease transmission and the impact of vaccination strategies is crucial for guiding public health interventions and optimizing epidemic control efforts. In this study, we developed a comprehensive mathematical model, termed $ S{S}_{v}I{H}_{1}C{H}_{2}RD $, to elucidate the dynamics of the COVID-19 epidemic in Thailand. The model incorporates key epidemiological parameters, vaccination rates, and disease progression stages to assess the effectiveness of different vaccination strategies in curbing disease transmission. Parameter estimation and model fitting were conducted using real-world data from COVID-19 patients in Thailand, enabling the simulation of epidemic scenarios and the exploration of optimal vaccination rates. Our results showed that optimizing vaccination strategies, particularly by administering approximately 119,625 doses per day, can significantly reduce the basic reproduction number ($ {R}_{0} $) below 1, thereby accelerating epidemic control. Simulation results demonstrated that the optimal vaccination rate led to a substantial decrease in the number of infections, with the epidemic projected to be completely eradicated from the population by June 19, 2022. These findings underscore the importance of targeted vaccination efforts and proactive public health interventions in mitigating the spread of COVID-19 and minimizing the burden on healthcare systems. Our study provides valuable insights into the optimization of vaccination strategies for epidemic control, offering guidance for policymakers and healthcare authorities in Thailand and beyond. By leveraging mathematical modeling techniques and real-world data, stakeholders can develop evidence-based strategies to combat the COVID-19 pandemic and safeguard public health.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3934/mbe.2024298 | DOI Listing |
Proc Natl Acad Sci U S A
February 2025
U.S. Military HIV Research Program, Center for Infectious Disease Research, Walter Reed Army Institute of Research, Silver Spring, MD 20910.
HIV-1 envelope broadly neutralizing antibodies represent a promising component of HIV-1 cure strategies. To evaluate the therapeutic efficacy of combination monoclonal antibodies (mAbs) in a rigorous nonhuman primate model, we tested different combinations of simian immunodeficiency virus (SIV) neutralizing mAbs in SIVmac251-infected rhesus macaques. Antiretroviral therapy-suppressed animals received anti-SIV mAbs targeting multiple Env epitopes spanning analytical treatment interruption (ATI) in 3 groups (n = 7 each): i) no mAb; ii) 4-mAb combination; and iii) 2-mAb combination.
View Article and Find Full Text PDFBrief Bioinform
November 2024
School of Computer Science, Northwestern Polytechnical University, Xi'an, 710129 Shaanxi, China.
The identification of neoantigens is crucial for advancing vaccines, diagnostics, and immunotherapies. Despite this importance, a fundamental question remains: how to model the presentation of neoantigens by major histocompatibility complex class I molecules and the recognition of the peptide-MHC-I (pMHC-I) complex by T cell receptors (TCRs). Accurate prediction of pMHC-I binding and TCR recognition remains a significant computational challenge in immunology due to intricate binding motifs and the long-tail distribution of known binding pairs in public databases.
View Article and Find Full Text PDFDiscov Nano
January 2025
Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
Some of the most crucial turning points in the treatment strategies for some major infectious diseases including AIDS, malaria, and TB, have been reached with the introduction of antimicrobials and vaccines. Drug resistance and poor effectiveness are key limitations that need to be overcome. Conventional liposomes have been explored as a delivery system for infectious diseases bioactives to treat infectious diseases to provide an efficient approach to maximize the therapeutic outcomes, drug stability, targetability, to reduce the side-effects of antimicrobials, and enhance vaccine performance where necessary.
View Article and Find Full Text PDFJ Epidemiol Glob Health
January 2025
Department of Community Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.
Background: Rabies is a preventable yet deadly public health threat. Despite the availability of effective vaccines for both humans and animals, the persistence of rabies-related fatalities underscores the need for enhanced public education strategies. This study aimed to develop and validate a Rabies Health Education Module delivered via a Massive Open Online Course, targeting adult dog owners in Kelantan, Malaysia.
View Article and Find Full Text PDFAnn Med
December 2025
College of Public Health, Institute of Health Data Analytics and Statistics, National Taiwan University, Taipei, Taiwan.
Background: Despite global declines in cervical cancer incidence, certain regions observe unexpected rising trends among younger generations.
Methods: This study uses the age-period-cohort model to examine long-term incidence trends of invasive cervical cancer in Taiwan. Data were sourced from the Taiwan Cancer Registry.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!